Kelly Martin, Radius Health CEO
VC firms take osteoporosis drugmaker Radius Health private for almost $900M
After attacks from activist investors and disappointing returns on share prices, Radius Health has now agreed to new ownership, a direction resulting in leaving the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.